|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/6883 | (2018.01) |
| C12Q 1/6883 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| C12Q2600/156 | (2013.01) | ||
| C07K 16/28 | (2006.01) | ||
| C07K 16/2875 | (2013.01) | ||
| A61P 1/00 | (2006.01) | ||
| A61P 1/00 | (2018.01) | ||
| A61P 1/04 | (2018.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 43/00 | (2018.01) |
| (11) | Number of the document | 3639841 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19199149.6 |
| Date of filing the European patent application | 2014-03-27 | |
| (97) | Date of publication of the European application | 2020-04-22 |
| (45) | Date of publication and mention of the grant of the patent | 2023-09-06 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201361805806 P | 2013-03-27 | US | |
| 201361872020 P | 2013-08-30 | US |
| (72) |
SHIH, David Q. , US
TARGAN, Stephan R. , US
LI, Dalin , US
BILSBOROUGH, Janine , US
|
| (73) |
Cedars-Sinai Medical Center ,
8700 Beverly Boulevard, Los Angeles, CA 90048,
US
|
| (54) | TREATING FIBROSIS BY INHIBITING TL1A |
| TREATING FIBROSIS BY INHIBITING TL1A |